The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
Official Title: A Randomized, Double-Blind Trial Comparing Linezolid To Vancomycin In The Empiric Treatment Of Febrile Neutropenic Oncology Patients With Suspected Gram-Positive Infections
Study ID: NCT00035425
Brief Summary: This study will treat patients who have fever and neutropenia (after cancer chemotherapy) that is possibly due to a specific bacteria (gram positive bacteria).
Detailed Description:
Minimum Age: 13 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Pfizer Investigational Site, Los Angeles, California, United States
Pfizer Investigational Site, Springfield, Illinois, United States
Pfizer Investigational Site, Springfield, Illinois, United States
Pfizer Investigational Site, Springfield, Illinois, United States
Pfizer Investigational Site, Springfield, Illinois, United States
Pfizer Investigational Site, Bronx, New York, United States
Pfizer Investigational Site, Bronx, New York, United States
Pfizer Investigational Site, Houston, Texas, United States
Pfizer Investigational Site, Richmond, Virginia, United States
Pfizer Investigational Site, Richmond, Virginia, United States
Pfizer Investigational Site, Richmond, Virginia, United States
Pfizer Investigational Site, Richmond, Virginia, United States
Pfizer Investigational Site, Richmond, Virginia, United States
Pfizer Investigational Site, Federal Way, Washington, United States
Pfizer Investigational Site, Lakewood, Washington, United States
Pfizer Investigational Site, Tacoma, Washington, United States
Pfizer Investigational Site, Buenos Aires, , Argentina
Pfizer Investigational Site, Cordoba, , Argentina
Pfizer Investigational Site, Mendoza, , Argentina
Pfizer Investigational Site, Porto Alegre, RS, Brazil
Pfizer Investigational Site, Porto Alegre, RS, Brazil
Pfizer Investigational Site, Sao Paulo, SP, Brazil
Pfizer Investigational Site, São Paulo, SP, Brazil
Pfizer Investigational Site, São Paulo, , Brazil
Pfizer Investigational Site, São Paulo, , Brazil
Pfizer Investigational Site, Santiago, , Chile
Pfizer Investigational Site, Bogota, Bogota. DC, Colombia
Pfizer Investigational Site, Bogota, Bogota. DC, Colombia
Pfizer Investigational Site, Medellin, , Colombia
Pfizer Investigational Site, Helsinki, , Finland
Pfizer Investigational Site, Zapopan, Jalisco, Mexico
Pfizer Investigational Site, Monterrey, Nuevo Leon, Mexico
Pfizer Investigational Site, Mexico D.f., , Mexico
Pfizer Investigational Site, Lahore, Punjab, Pakistan
Pfizer Investigational Site, Karachi, , Pakistan
Pfizer Investigational Site, Lima, , Peru
Pfizer Investigational Site, Lima, , Peru
Pfizer Investigational Site, Caracas, Distrito Federal, Venezuela
Pfizer Investigational Site, Caracas, , Venezuela
Pfizer Investigational Site, , ,
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR